1. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma
    Jiabi Qin et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  2. Role of long non-coding RNA in drug resistance in non-small cell lung cancer.
    Leirong Wang et al, 2018, Thorac Cancer CrossRef
  3. Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer
    Wei Feng et al, 2018, Cancer Sci CrossRef
  4. Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer
    Qi Yang et al, 2018, Toxicology and Applied Pharmacology CrossRef
  5. The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC
    Xuehao Li et al, 2018, Cell Cycle CrossRef
  6. Emerging roles of long non-coding RNAs in tumor metabolism
    Hui Sun et al, 2018, J Hematol Oncol CrossRef
  7. The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targettingmiR-377/CASP1 axis
    ZheXing Wang et al, 2018, Biosci. Rep. CrossRef
  8. Microarray profiling and co-expression network analysis of lncRNAs and mRNAs in ovarian cancer
    Ce Gao et al, 2019, Cell Death Discov. CrossRef
  9. LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge
    Changjiang Feng et al, 2019, Archivos de Bronconeumología CrossRef
  10. LncRNA-LOC101928316 contributes to gastric cancer progression through regulating PI3K-Akt-mTOR signaling pathway
    Chengyun Li et al, 2019, Cancer Med CrossRef
  11. Knockdown of lncRNA BLACAT1 reverses the resistance of afatinib to non-small cell lung cancer via modulating STAT3 signalling.
    Degui Shu et al, 2020, J Drug Target CrossRef
  12. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis
    Zongmiao Wan et al, 2019, Experimental Cell Research CrossRef
  13. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response
    Abril Marcela Herrera-Solorio et al, 2017, Clin Epigenet CrossRef
  14. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway
    Yíng Wang et al, 2017, J Cell Physiol CrossRef
  15. LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge
    Changjiang Feng et al, 2019, Archivos de Bronconeumología (English Edition) CrossRef
  16. Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma
    Zekai Huang et al, 2020, Anti-Cancer Drugs CrossRef
  17. Long non‐coding RNAs: How to regulate the metastasis of non–small‐cell lung cancer
    Cheng Fang et al, 2020, J Cell Mol Med CrossRef
  18. Non-coding RNAs in Lung Cancer Chemoresistance
    Priya Mondal et al, 2020, CDM CrossRef
  19. Long non-coding RNAs regulate drug resistance in cancer
    Kaisheng Liu et al, 2020, Mol Cancer CrossRef
  20. The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors
    Chao Tu et al, 2020, Cancer Cell Int CrossRef

  21. The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4


    Zhiwei Xing et al, 2020, OTT CrossRef
  22. LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers
    Chen Chen et al, 2020, Cancer Letters CrossRef
  23. Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer
    Jingjing Shi et al, 2020, Computational Biology and Chemistry CrossRef
  24. Non-coding RNAs underlying chemoresistance in gastric cancer
    Arash Poursheikhani et al, 2020, Cell Oncol. CrossRef
  25. HOTAIR induces EGFR-TKIs Resistance in Non-Small Cell Lung Cancer through Epithelial-Mesenchymal Transition
    Qi Wang et al, 2020, Lung Cancer CrossRef
  26. Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer
    Dominik A. Barth et al, 2020, ncRNA CrossRef
  27. Interaction of long-chain non-coding RNAs and important signaling pathways on human cancers (Review)
    Wei Sun et al, 2018, Int J Oncol CrossRef
  28. The anticancer effects of Cucurbitacin I inhibited cell growth of human non‑small cell lung cancer through PI3K/AKT/p70S6K pathway
    Xueqiang Zhu et al, 2017, Mol Med Report CrossRef
  29. Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma
    Yuta Nakano et al, 2019, Int J Oncol CrossRef
  30. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Rong Yan et al, 0 CrossRef
  31. MIR31HG promotes cell proliferation and invasion by activating the Wnt/β-catenin signaling pathway in non-small cell lung cancer.
    Shuaiyu Zheng et al, 2019, Oncol Lett CrossRef
  32. In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway
    Shuang Wu et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  33. The role of long non‐coding RNAs in drug resistance of cancer
    He‐da Zhang et al, 2020, Clinical Genetics CrossRef
  34. Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer
    Manuela La Montagna et al, 2020, Cancer Gene Ther CrossRef
  35. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Thomas Worst, 0 CrossRef
  36. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer
    Yu Chen et al, 2021, Clinical and Translational Medicine CrossRef
  37. Identification of a prognostic long noncoding RNA signature in lung squamous cell carcinoma: a population-based study with a mean follow-up of 3.5 years
    Rongjiong Zheng et al, 2021, Arch Public Health CrossRef
  38. LncRNA MIR31HG Drives Oncogenicity by Inhibiting the Limb-Bud and Heart Development Gene (LBH) during Oral Carcinoma
    Kuo-Wei Chang et al, 2021, IJMS CrossRef
  39. Long non‐coding RNA MIR31HG as a prognostic predictor for malignant cancers: A meta‐ and bioinformatics analysis
    Yuanfeng Wei et al, 2021, J Clin Lab Anal CrossRef
  40. Long Noncoding RNA Urothelial Carcinoma-Associated 1 Promotes the Proliferation and Metastasis of Human Lung Tumor Cells by Regulating MicroRNA-144.
    Dagang Li et al, 2018, Oncol Res CrossRef
  41. Long Noncoding RNA LOC554202 Predicts a Poor Prognosis and Correlates with Immune Infiltration in Thyroid Cancer
    Cheng Chen et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  42. Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth
    Chia-Wei Weng et al, 2022, IJMS CrossRef
  43. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
    Maliheh Entezari et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  44. Knockdown of GSG2 inhibits the development and progression of non-small cell lung cancer in vitro and in vivo
    Fan Zhang et al, 2022, Cell Cycle CrossRef
  45. Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
    Lingyan Xiao et al, 2022, Front. Mol. Biosci. CrossRef
  46. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K / AKT signaling pathway
    Bo Feng et al, 2022, Clinical Laboratory Analysis CrossRef
  47. LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing
    Qi Wen Chen et al, 2023, Clinical & Translational Med CrossRef
  48. Impact of MIR31HG polymorphisms on risk of breast cancer in Chinese women
    Ying Wei et al, 2023, Int J Clin Oncol CrossRef
  49. Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer
    Lan Sun et al, 2023, PRA CrossRef
  50. Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance
    Detian Liu et al, 2023, Front. Genet. CrossRef
  51. MIR31HG, a potential lncRNA in human cancers and non-cancers
    Luxi Ruan et al, 2023, Front. Genet. CrossRef
  52. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer
    Waleed Hassan Almalki, 2023, Pathology - Research and Practice CrossRef
  53. Long non-coding RNA and Evolving drug resistance in lung cancer
    Meibin Wang et al, 2023, Heliyon CrossRef
  54. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer
    Syam Mohan et al, 2023, Pathology - Research and Practice CrossRef
  55. lncRNAs’p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer
    Sulieman Ibrahim Shelash et al, 2024, Med Oncol CrossRef
  56. Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: recent insights and potential clinical applications
    Mehrdad Hashemi et al, 2024, Non-coding RNA Research CrossRef